Roivant Sciences Ltd.ROIVNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank67
3Y CAGR-0.1%
5Y CAGR+18.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-0.1%/yr
Annual compound
5Y CAGR
+18.2%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$599.31M+1.3%
2024$591.41M+42.1%
2023$416.13M-30.7%
2022$600.51M-22.5%
2021$775.03M+198.2%
2020$259.88M-22.6%
2019$335.77M-